AKO-B
Embotelladora Andina S.A.
AKO-B lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover.
AKO-B Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
AKO-B's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
AKO-B PE Valuation
AKO-B has no meaningful PE right now: it lost money over the past year.
AKO-B Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for AKO-B, but weaker profitability.
AKO-B Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.90 | +147% |
| Q2 2026 | $1.86 | +296% |
| Q1 2026 | $1.87 | +619% |
| Q4 2025 | $1.32 | +110% |
| Q3 2025 | $0.77 | -14% |
| Q2 2025 | $0.47 | -63% |
| Q1 2025 | $0.26 | -80% |
| Q4 2024 | $0.63 | -44% |
AKO-B earned $1.90 per share over the past year, up 147% from the year before.
AKO-B Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $897.5M | +12% |
| Q2 2026 | $820.9M | +11% |
| Q1 2026 | $925.2M | +4.1% |
| Q4 2025 | $952.6M | 0% |
| Q3 2025 | $801.2M | +10% |
| Q2 2025 | $738.9M | +9.8% |
| Q1 2025 | $889.1M | +9.2% |
| Q4 2024 | $953M | +59% |
AKO-B's revenue is growing: $898M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -0.1 points |
| Q2 2026 | 11% | -0.2 points |
| Q1 2026 | 16% | +1.2 points |
| Q4 2025 | 16% | +0.5 points |
| Q3 2025 | 11% | +0.5 points |
| Q2 2025 | 11% | -0.1 points |
| Q1 2025 | 15% | -0.6 points |
| Q4 2024 | 16% | -2.1 points |
AKO-B's operating margin was 11% last quarter, about level with the same quarter a year ago.
AKO-B Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $107.6M | +1410% |
| Q1 2026 | $35.4M | -5.1% |
| Q4 2025 | $129.4M | -63% |
| Q3 2025 | $9.6M | +4.7% |
AKO-B's free cash flow has been positive every quarter since late 2024: $282M over the past year, down 30% from the year before.
AKO-B Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.5x | Healthy |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.6x | Healthy |
AKO-B's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
AKO-B Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.3 | Neutral |
| Stochastic | 33.5 | Neutral |
AKO-B's weekly RSI is 43 (neutral) and its Stochastic is 34 (neutral).
AKO-B PE vs Consumer Defensive Sector
| Metric | AKO-B | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
AKO-B has no meaningful PE right now: it lost money over the past year.
AKO-B Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.2 | 7.1% below |
| 20 week MA | $29.7 | 8.7% below |
| 50 week MA | $29.0 | 6.5% below |
| 100 week MA | $26.1 | 3.9% above |
| 200 week MA | $21.1 | 28% above |
AKO-B has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 28% above its 200-week average.
AKO-B Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.9 | $15.7 | -12% |
| 2021 | $15.7 | $12.4 | -21% |
| 2022 | $12.4 | $14.0 | +13% |
| 2023 | $14.0 | $14.9 | +6.5% |
| 2024 | $14.9 | $18.5 | +24% |
| 2025 | $18.5 | $27.5 | +49% |
| 2026 YTD | $27.5 | $27.1 | -1.6% |
AKO-B has finished higher in four of the last six years. It's down 1.6% so far in 2026.